Let's stand up to COVID-19, while sitting at home

You could help in the fight against COVID-19 and help bring a new treatment to people like you across the country, by joining our clinical trial.

Gaming-Site-Hero_02 1.png

WHO CAN TAKE PART?

You can participate from home in these locations

We are conducting a home-based clinical trial to determine whether short-term treatment with an existing medication reduces the risk of mortality and lung complications related to COVID-19.

ColCorona is a randomized, placebo-controlled study. It is double-blind - which means neither doctor nor patient will know whether you are taking the trial medication or a placebo.

If you meet all of the inclusion and none of the exclusion criteria, you will be invited to take part for 30 days where you will be supplied with a course of tablets to take orally.

icon_checkmark.png

United States: New York City Tri-State area, San Francisco, Los Angeles, Bakersfield, Downey, Miami, Jacksonville, Houston, Dallas, Phoenix, Yuma, Rochester, Tupelo, Greenville, Chapel Hill, Little Rock

icon_checkmark.png

Canada: Quebec, Ontario, British-Columbia

icon_checkmark.png

Spain: Madrid

icon_checkmark.png

South Africa: Cape Town

icon_checkmark.png

Brazil: San Paolo

icon_checkmark.png

Greece: Athens, Kozani, Alexandroupoli, Elefsina, Patras

KEY TRIAL REQUIREMENTS

You must have been diagnosed with and currently have COVID-19

icon_checkmark.png

You must be 40 years old or over

icon_checkmark.png

Trial lasts 30 days from home

icon_checkmark.png

Daily intake of study medication or placebo

icon_checkmark.png

You must not be in hospital due to COVID-19

icon_checkmark.png

You must not be pregnant or breastfeeding

icon_checkmark.png
 

SPONSORS

This clinical trial is supported by

sponsor_CGI_.jpg
logo-icm_EN.jpg
logo-quebec_EN.jpg
MHICC_logo_en_S.jpg
ici-NYU-langone.png
logo_universite-montreal.png
logo_omnimed.png
logo-pharma science.png
logo-dacima.jpg
logo-chu quebec.jpg
logo_Telus.png
FJRSD-logo-EN.png